<!DOCTYPE html><html><head><title> Pacifica Code Section 26-7-S8 </title><link rel="stylesheet" href="/assets/style.css"/></head><body>
<b><i>
                      Effective 5/8/2018</i></b>
<br>
<b>26-7-8.&nbsp;
          </b><b>Syringe exchange and education.</b>
<br>
<a id="26-7-8(1)" name="26-7-8(1)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(1)</td><td style="width:99%">
The following may operate a syringe exchange program in the state to prevent the transmission of disease and reduce morbidity and mortality among individuals who inject drugs, and those individuals' contacts:
<a id="26-7-8(1)(a)" name="26-7-8(1)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
a government entity, including:<a id="26-7-8(1)(a)(i)" name="26-7-8(1)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the department;</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(a)(ii)" name="26-7-8(1)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a local health department, as defined in Section <a href="../../Title26A/Chapter1/26A-1-S102.html?v=C26A-1-S102_2018031520180315">26A-1-102</a>;</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(a)(iii)" name="26-7-8(1)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the Division of Substance Abuse and Mental Health within the Department of Human Services; or</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(a)(iv)" name="26-7-8(1)(a)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
a local substance abuse authority, as defined in Section <a href="../../Title62A/Chapter15/62A-15-S102.html?v=C62A-15-S102_2018032220180322">62A-15-102</a>;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(b)" name="26-7-8(1)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
a nongovernment entity, including:<a id="26-7-8(1)(b)(i)" name="26-7-8(1)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
a nonprofit organization; or</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(b)(ii)" name="26-7-8(1)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
a for-profit organization; or</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(1)(c)" name="26-7-8(1)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
any other entity that complies with Subsections <a href="#26-7-8(2)">(2)</a> and <a href="#26-7-8(4)">(4)</a>.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(2)" name="26-7-8(2)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(2)</td><td style="width:99%">
An entity operating a syringe exchange program in the state shall:
<a id="26-7-8(2)(a)" name="26-7-8(2)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
facilitate the exchange of an individual's used syringe for one or more new syringes in sealed sterile packages;</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(b)" name="26-7-8(2)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
ensure that a recipient of a new syringe is given verbal and written instruction on:<a id="26-7-8(2)(b)(i)" name="26-7-8(2)(b)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
methods for preventing the transmission of blood-borne diseases, including hepatitis C and human immunodeficiency virus; and</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(b)(ii)" name="26-7-8(2)(b)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
options for obtaining:
<a id="26-7-8(2)(b)(ii)(A)" name="26-7-8(2)(b)(ii)(A)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(A)</td><td style="width:99%">
services for the treatment of a substance use disorder;</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(b)(ii)(B)" name="26-7-8(2)(b)(ii)(B)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(B)</td><td style="width:99%">
testing for a blood-borne disease; and</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(b)(ii)(C)" name="26-7-8(2)(b)(ii)(C)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(C)</td><td style="width:99%">
an opiate antagonist under <a href="../../Title26/Chapter55/26-55.html?v=C26-55_2016051020160510">Chapter 55, Opiate Overdose Response Act</a>; and</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(c)" name="26-7-8(2)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
report annually to the department the following information about the program's activities:<a id="26-7-8(2)(c)(i)" name="26-7-8(2)(c)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the number of individuals who have exchanged syringes;</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(c)(ii)" name="26-7-8(2)(c)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the number of used syringes exchanged for new syringes; and</td>
</tr>
</tbody></table>
<a id="26-7-8(2)(c)(iii)" name="26-7-8(2)(c)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the number of new syringes provided in exchange for used syringes.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(3)" name="26-7-8(3)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(3)</td><td style="width:99%">
No later than October 1, 2017, and every two years thereafter, the department shall report to the Legislature's Health and Human Services Interim Committee on:
<a id="26-7-8(3)(a)" name="26-7-8(3)(a)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(a)</td><td style="width:99%">
the activities and outcomes of syringe programs operating in the state, including:<a id="26-7-8(3)(a)(i)" name="26-7-8(3)(a)(i)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(i)</td><td style="width:99%">
the number of individuals who have exchanged syringes;</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(a)(ii)" name="26-7-8(3)(a)(ii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(ii)</td><td style="width:99%">
the number of used syringes exchanged for new syringes;</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(a)(iii)" name="26-7-8(3)(a)(iii)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iii)</td><td style="width:99%">
the number of new syringes provided in exchange for used syringes;</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(a)(iv)" name="26-7-8(3)(a)(iv)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(iv)</td><td style="width:99%">
the impact of the programs on blood-borne infection rates; and</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(a)(v)" name="26-7-8(3)(a)(v)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(v)</td><td style="width:99%">
the impact of the programs on the number of individuals receiving treatment for a substance use disorder;</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(b)" name="26-7-8(3)(b)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(b)</td><td style="width:99%">
the potential for additional reductions in the number of syringes contaminated with blood-borne disease if the programs receive additional funding;</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(c)" name="26-7-8(3)(c)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(c)</td><td style="width:99%">
the potential for additional reductions in state and local government spending if the programs receive additional funding;</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(d)" name="26-7-8(3)(d)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(d)</td><td style="width:99%">
whether the programs promote illicit use of drugs; and</td>
</tr>
</tbody></table>
<a id="26-7-8(3)(e)" name="26-7-8(3)(e)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(e)</td><td style="width:99%">
whether the programs should be continued, continued with modifications, or terminated.</td>
</tr>
</tbody></table>
</td>
</tr>
</tbody></table>
<a id="26-7-8(4)" name="26-7-8(4)"></a>
<table width="100%">
<tbody><tr>
<td style="vertical-align:text-top">(4)</td><td style="width:99%">
The department shall make rules, in accordance with <a href="../../Title63G/Chapter3/63G-3.html?v=C63G-3_1800010118000101">Title 63G, Chapter 3, Utah Administrative Rulemaking Act</a>, specifying how and when an entity operating a syringe exchange program shall make the report required by Subsection <a href="#26-7-8(2)(c)">(2)(c)</a>.</td>
</tr>
</tbody></table>
<br>
<br>Amended by Chapter <a href="http://le.utah.gov/UtahCode/ChapterLookup.jsp?chap=281&amp;sess=2018GS">281</a>, 2018 General Session<br>
</body></html>